Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

2nd Annual RNAi-Based Therapeutics Summit - June 2021 - Digital Event

Evvnt Promotion / evvnt
-
15.06.2021 - 17.06.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temi della conferenza
As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting efforts have now turned to a wide range of other diseases, from CNS, oncology, metabolism and more. Despite the growing momentum, much needs to be addressed in terms of targeted delivery, safety, and efficiency to fully unleash the therapeutic value of RNAi drugs.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Greg Hinkle Vice President, Research Informatics Alnylam Pharmaceuticals, Ekkehard Leberer Senior Director, R&D Alliance Management Sanofi, Julia Alterman Senior Scientist Khvorova Lab University of Massachusetts Medical School and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/733422-0?pid=4832
Mr. Customer Service
 
Categorie
Medicina General, Sanità Pubblica (Public Health)
Lingua
Inglese
Quote del Congresso
Conference Only: USD 1999.00, Conference + 1 Workshop: USD 2348.00, Conference + 2 Workshops: USD 2697.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceCharité International AcademyAlumni Club Medizinische Universität WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinnewTreeCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Akademie der ÄrzteAMREF - African Medical and Research Foundation